Investigational Site Number : 2030005

Ostrava - Poruba 70852

0 studies enrolling now · 4 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis, Type 1 Diabetes Mellitus

Studies at this site

• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed